Patents by Inventor Barbara E. Segelstein

Barbara E. Segelstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF
    Publication number: 20120322823
    Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.
    Type: Application
    Filed: August 28, 2012
    Publication date: December 20, 2012
    Inventors: Anton F. J. Fliri, Randall James Gallaschun, Christopher John O'Donnell, Jacob Bradley Schwarz, Barbara E. Segelstein
  • Heterocyclic sulfonamides, uses and pharmaceutical compositions thereof
    Patent number: 8278457
    Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.
    Type: Grant
    Filed: June 25, 2010
    Date of Patent: October 2, 2012
    Assignee: Pfizer Inc.
    Inventors: Anton F. J. Fliri, Randall James Gallaschun, Christopher John O'Donnell, Jacob Bradley Schwarz, Barbara E. Segelstein
  • Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof
    Publication number: 20110105533
    Abstract: The invention is directed to a class of compounds, including the pharmaceutically acceptable salts of the compounds, having the structure of formula I: as defined in the specification. The invention is also directed to compositions containing and uses of the compounds of formula I.
    Type: Application
    Filed: June 25, 2010
    Publication date: May 5, 2011
    Inventors: Anton F. J. Fliri, Randall James Gallaschun, Christopher John O'Donnell, Jacob Bradley Schwarz, Barbara E. Segelstein
  • NK1 antagonists
    Patent number: 7241798
    Abstract: The invention is to compounds exhibiting neurokinin inhibitory properties, pharmaceutical compositions comprising same and methods of treatment for neurokinin-mediated conditions.
    Type: Grant
    Filed: June 7, 2005
    Date of Patent: July 10, 2007
    Assignee: Pfizer Inc.
    Inventors: Barbara E. Segelstein, Travis T. Wager, Willard M. Welch
  • 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
    Publication number: 20040063940
    Abstract: The present invention relates to compounds of the formula I, 1
    Type: Application
    Filed: June 26, 2003
    Publication date: April 1, 2004
    Applicant: Pfizer Inc
    Inventors: Spiros Liras, Martin P. Allen, Barbara E. Segelstein
  • 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives
    Patent number: 6586431
    Abstract: The present invention relates to compounds of the formula I, wherein Z1, Z2, X, Q, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.
    Type: Grant
    Filed: May 31, 2000
    Date of Patent: July 1, 2003
    Assignee: Pfizer Inc
    Inventors: Spiros Liras, Martin P. Allen, Barbara E. Segelstein
  • 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
    Patent number: 6503905
    Abstract: The present invention relates to compounds of the formula I, wherein Z1, Z2, X, Q, R1, R2 and R3 are defined as in the specification, pharmaceutical compositions containing such compounds the use of such compounds to treat neurological and gastrointestinal disorders.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: January 7, 2003
    Assignee: Pfizer Inc
    Inventors: Spiros Liras, Martin P. Allen, Barbara E. Segelstein
  • Naphthalene derivatives
    Publication number: 20020058811
    Abstract: Compounds of formula (1) where R1 is of formulae (II), (III), or (IV), or (V); R2 is —R4, —O—R4, —O—S(O)2—R4, —NR4R5, R4—(CH2)b—NH(C═X)—(CH2)c—, R4—(CH2)b—O(C—O)NH—(CH2)c—(C═O)NH—, R4—(C═O)NH—(C═O)NH—, —(CH2)b—NH(C═X)—(CH2)c—R4, R4—(CH2)b—O(C═O)CH2)c—, —(CH2)b—O(C═O)—(CH2)c—R4, —NH(C═X)NH—R4, R4—O(C═O)O—, —O(C═O)NH—R4, R4—O(C═O)NH—, —(CH2)b—(C═O)—(CH2)c—R4, —NH—S(O)2—R4, —C(OH)R4R5, —CH(OH)—R4, —(C═O)—NR4, —CN, —NO2, substituted C1 to C6 alkyl, substituted or unsubstituted C1 to C6 alkenyl, or substituted or unsubstituted C1 to C6 alkynyl, said substituted moieties substituted with a moiety of the formulae —R4, —R4R5, &md
    Type: Application
    Filed: December 3, 2001
    Publication date: May 16, 2002
    Inventors: Bertrand L. Chenard, John E. Macor, Barbara E. Segelstein
  • Pyrazinyl-substituted naphthalene derivatives
    Publication number: 20010004669
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: January 10, 2001
    Publication date: June 21, 2001
    Inventors: Bertrand L. Chenard, John E. Macor, Barbara E. Segelstein